Skip to content

Therapeutic regimens for Vitamin D3 deficiency

Comparison of two therapeutic regimens Vitamin D3 deficiency in the first trimester of pregnancy on the level of vitamin D3 in the second trimester of pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016040527227N1
Enrollment
200
Registered
2017-07-10
Start date
2016-06-19
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamine D deficiency. Vitamin D deficiency

Interventions

Intervention 1: Group Therapy A: Oral Treatment of vitamin D perl 50,000 units once a week to 10 weeks. Intervention 2: Group Therapy B, Oral Tretment of vitamin D Tablet 1000 unite daily for 10

Sponsors

Tarbiat Modares University of Medical Science, Tehran
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: Serum Vitamin D level is less than 30 ng / ml Gestational age less than 14 weeks Age 18-42 years Not chronic disease, impaired absorption and metabolism of food Single pregnancy Not receiving any supplement except multivitamins to 400 unite Vitamin D3, folic acid, iron and calcium with 400 units Vitamin D3 Having Iranian nationality

Exclusion criteria

Exclusion criteria: Unwillingness to continue participating in the study The occurrence of any complication related to treatment (nausea, vomiting, fatigue, weakness, headache, frequent urination, dry mouth) Do not use the correct medicine People who have special diets, including vegetarian diet, etc.

Design outcomes

Primary

MeasureTime frame
Check of the serum levels of vitamin D. Timepoint: First Trimester and Second Trimester. Method of measurement: Blood Exam.

Secondary

MeasureTime frame
Delete. Timepoint: Delete. Method of measurement: Delete.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Rostami

Tarbiat Modares University of Medicai Science

farahnaz.rostami@modares.ac.ir+98 21 6690 1515

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026